We are live on
!
Find out more
MG
Meditor Group Portfolio holdings
AUM
$48.1M
1-Year Est. Return
38.67%
This Fund
S&P 500
This Quarter
Est. Return
+11.53%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$77.1M
AUM Growth
-$38M
(-33%)
Cap. Flow
-$49.1M
Cap. Flow
% of AUM
-63.59%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
4
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelixis
EXEL
|
+$41.8M |
| 2 |
WisdomTree India Earnings Fund ETF
EPI
|
+$3.3M |
| 3 |
iShares MSCI India ETF
INDA
|
+$3.09M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$885K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.7% |
Similar funds
BHCM
VMV
BHH
LAMC
MAM
BCM
LOF
CLCM
Meditor Group's Q3 2023 Portfolio in Review
As of Q3 2023, Meditor Group held 4 positions worth $77.1M, down 33% from $115M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Meditor Group withdrew a net $49.1M in Q3 2023, reducing 4 holdings. Its largest reduction was Exelixis, cutting an estimated $41.8M.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 91% a quarter earlier.
- Meditor Group's biggest Q3 2023 reduction was Exelixis, cutting an estimated $41.8M.
- Meditor Group's ten largest holdings make up 100% of its $77.1M portfolio in Q3 2023.
- Meditor Group opened 0 new positions and closed 0 in Q3 2023.
- Meditor Group's portfolio value fell 33% quarter-over-quarter to $77.1M.
Based on Meditor Group's 13F filing for Q3 2023, filed 31 Oct 2023.